Vir Biotechnology (VIR) Intangibles (2018 - 2026)

Vir Biotechnology has disclosed Intangibles across 9 years of filings, most recently posting $7.8 million for Q1 2026.

• Intangibles for Q1 2026 came in at $7.8 million, down 3.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.8 million (down 3.65% YoY), and the FY2025 annual result was $7.8 million, down 3.33% from the prior year.
• Intangibles came in at $7.8 million for Q1 2026 at Vir Biotechnology, down from $7.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $33.2 million in Q1 2022 to a low of $7.8 million in Q1 2026.
• The 5-year median for Intangibles is $22.5 million (2024), against an average of $20.4 million.
• Across the five-year window, Intangibles declined 1.58% in 2022 and sank 64.07% in 2025, its largest moves.
• Vir Biotechnology's Intangibles stood at $32.8 million in 2022, then tumbled by 31.11% to $22.6 million in 2023, then sank by 64.02% to $8.1 million in 2024, then decreased by 3.33% to $7.8 million in 2025, then declined by 0.93% to $7.8 million in 2026.
• The last three Intangibles figures came in at $7.8 million (Q1 2026), $7.8 million (Q4 2025), and $7.9 million (Q3 2025), per Business Quant data.